Hepatitis B virus resistance to entecavir in nucleoside naïve patients: Does it exist? (Q45409700)

From Wikidata

Jump to navigation Jump to search

scientific article published in December 2006

edit

Language	Label	Description	Also known as
English	Hepatitis B virus resistance to entecavir in nucleoside naïve patients: Does it exist?	scientific article published in December 2006

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17133478

retrieved

14 December 2017

editorial

0 references

title

Hepatitis B virus resistance to entecavir in nucleoside naïve patients: Does it exist? (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17133478

retrieved

14 December 2017

main subject

Hepatitis B virus

1 reference

based on heuristic

inferred from title

entecavir

1 reference

based on heuristic

inferred from title

author name string

Fabien Zoulim

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17133478

retrieved

14 December 2017

language of work or name

English

0 references

publication date

1 December 2006

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17133478

retrieved

14 December 2017

published in

Hepatology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17133478

retrieved

14 December 2017

volume

44

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17133478

retrieved

14 December 2017

issue

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17133478

retrieved

14 December 2017

page(s)

1404-1407

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17133478

retrieved

14 December 2017

cites work

Antiviral therapy of chronic hepatitis B.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21451

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Lamivudine for patients with chronic hepatitis B and advanced liver disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21451

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21451

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanism of viral persistence and resistance to nucleoside and nucleotide analogs in chronic hepatitis B virus infection

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21451

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Entecavir for Treatment of Lamivudine-Refractory, HBeAg-Positive Chronic Hepatitis B

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21451

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21451

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21451

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21451

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term entecavir treatment results in sustained antiviral efficacy and prolonged life span in the woodchuck model of chronic hepatitis infection.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21451

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21451

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Susceptibility to antivirals of a human HBV strain with mutations conferring resistance to both lamivudine and adefovir.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21451

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Evolution of multi-drug resistant hepatitis B virus during sequential therapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21451

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Entecavir resistance is rare in nucleoside naïve patients with hepatitis B

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21451

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Evolution of hepatitis B virus polymerase gene sequence during famciclovir therapy for chronic hepatitis B.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21451

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Dynamics of hepatitis B virus resistance to lamivudine

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21451

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

A new strategy for studying in vitro the drug susceptibility of clinical isolates of human hepatitis B virus.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21451

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Infection of a human hepatoma cell line by hepatitis B virus

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21451

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic infection with hepatitis B viruses and antiviral drug evaluation in uPA mice after liver repopulation with tupaia hepatocytes

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21451

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

The competing roles of virus replication and hepatocyte death rates in the emergence of drug-resistant mutants: theoretical considerations.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21451

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Entecavir versus lamivudine for HBeAg positive and negative chronic hepatitis B

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21451

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Entecavir: a new treatment option for chronic hepatitis B.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21451

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Selection of a multiple drug-resistant hepatitis B virus strain in a liver-transplanted patient.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21451

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination of nucleoside analogues in the treatment of chronic hepatitis B virus infection: lesson from experimental models.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21451

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1002/HEP.21451

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17133478

retrieved

14 December 2017

PubMed publication ID

17133478

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17133478

retrieved

14 December 2017

ResearchGate publication ID

6666073

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45409700&oldid=1561224970"